CD38 modulated chemotaxis

Details for Australian Patent Application No. 2006214321 (hide)

Owner Trudeau Institute Lund, F. Randall, T. Partida-Sandchez, S.

Inventors Lund, Frances E.; Partida-Sandchez, Santiago; Randall, Troy D.

Agent Freehills

Pub. Number AU-A-2006214321

PCT Pub. Number WO2006/088951

Priority 11/115,964 26.04.05 US; 11/058,924 15.02.05 US

Filing date 14 February 2006

Wipo publication date 24 August 2006

International Classifications

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/088951 Priority application(s): WO2006/088951

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214325-Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells

2006214320-Methods and reagents for treatment and diagnosis of age-related macular degeneration